Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Kheifetz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Plos Computational Biology|March 7, 2019
Modeling individual time courses of thrombopoiesis during multi-cyclic chemotherapyYuri Kheifetz, Markus Scholz
British Journal of Clinical Pharmacology|December 31, 2020
Individual prediction of thrombocytopenia at next chemotherapy cycle: Evaluation of dynamic model performancesYuri Kheifetz, Markus Scholz
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 8, 2014
Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integrationZvia Agur, Moran Elishmereni, Yuri Kheifetz
Journal of Cancer Research and Clinical Oncology|October 13, 2024
Predicting chemotherapy-induced thrombotoxicity by NARX neural networks and transfer learningMarie Steinacker, Yuri Kheifetz, Markus Scholz
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2014
Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive proteinYuri Kheifetz, Moran Elishmereni, Zvia Agur
Mathematical Biosciences and Engineering : MBE|April 8, 2010
Critical-point analysis for three-variable cancer angiogenesis modelsUrszula Forys, Yuri Kheifetz, Yuri Kogan
Heliyon|July 24, 2023
Individual modelling of haematotoxicity with NARX neural networks: A knowledge transfer approachMarie Steinacker, Yuri Kheifetz, Markus Scholz
Viruses|July 27, 2022
On the Parametrization of Epidemiologic Models-Lessons from Modelling COVID-19 EpidemicYuri Kheifetz, Holger Kirsten, Markus Scholz
Viruses|July 30, 2025
Modeling the Complete Dynamics of the SARS-CoV-2 Pandemic of Germany and Its Federal States Using Multiple Levels of DataYuri Kheifetz, Holger Kirsten, Andreas Schuppert, et al.
Plos Computational Biology|October 25, 2011
An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancersMoran Elishmereni, Yuri Kheifetz, Henrik Søndergaard, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Plos Computational Biology|March 7, 2019
Modeling individual time courses of thrombopoiesis during multi-cyclic chemotherapyYuri Kheifetz, Markus Scholz
British Journal of Clinical Pharmacology|December 31, 2020
Individual prediction of thrombocytopenia at next chemotherapy cycle: Evaluation of dynamic model performancesYuri Kheifetz, Markus Scholz
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 8, 2014
Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integrationZvia Agur, Moran Elishmereni, Yuri Kheifetz
Journal of Cancer Research and Clinical Oncology|October 13, 2024
Predicting chemotherapy-induced thrombotoxicity by NARX neural networks and transfer learningMarie Steinacker, Yuri Kheifetz, Markus Scholz
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2014
Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive proteinYuri Kheifetz, Moran Elishmereni, Zvia Agur
Mathematical Biosciences and Engineering : MBE|April 8, 2010
Critical-point analysis for three-variable cancer angiogenesis modelsUrszula Forys, Yuri Kheifetz, Yuri Kogan
Heliyon|July 24, 2023
Individual modelling of haematotoxicity with NARX neural networks: A knowledge transfer approachMarie Steinacker, Yuri Kheifetz, Markus Scholz
Viruses|July 27, 2022
On the Parametrization of Epidemiologic Models-Lessons from Modelling COVID-19 EpidemicYuri Kheifetz, Holger Kirsten, Markus Scholz
Viruses|July 30, 2025
Modeling the Complete Dynamics of the SARS-CoV-2 Pandemic of Germany and Its Federal States Using Multiple Levels of DataYuri Kheifetz, Holger Kirsten, Andreas Schuppert, et al.
Plos Computational Biology|October 25, 2011
An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancersMoran Elishmereni, Yuri Kheifetz, Henrik Søndergaard, et al.
Pageof 2